TY - JOUR
TI - Pembrolizumab monotherapy in patients with primary refractory classical hodgkin lymphoma who relapsed after salvage autologous stem cell transplantation and/or brentuximab vedotin therapy: KEYNOTE-087 subgroup analysis
AU - Zinzani, P.L.
AU - Chen, R.
AU - Armand, P.
AU - Johnson, N.A.
AU - Brice, P.
AU - Radford, J.
AU - Ribrag, V.
AU - Molin, D.
AU - Vassilakopoulos, T.P.
AU - Tomita, A.
AU - von Tresckow, B.
AU - Shipp, M.A.
AU - Lin, J.
AU - Nahar, A.
AU - Balakumaran, A.
AU - Moskowitz, C.H.
JO - Clinical Lymphoma Myeloma and Leukemia
PY - 2020
VL - 61
TODO - 4
SP - 950-954
PB - Taylor and Francis Ltd.
SN - null
TODO - 10.1080/10428194.2019.1702178
TODO - brentuximab vedotin;  pembrolizumab;  antibody conjugate;  brentuximab vedotin;  monoclonal antibody;  pembrolizumab, adult;  adverse drug reaction;  allogeneic stem cell transplantation;  autologous stem cell transplantation;  bone marrow transplantation;  cancer regression;  cancer survival;  classical Hodgkin lymphoma;  clinical assessment;  clinical effectiveness;  clinical evaluation;  cohort analysis;  colitis;  cytokine release syndrome;  disease exacerbation;  drug efficacy;  drug safety;  drug withdrawal;  epilepsy;  female;  follow up;  graft versus host reaction;  human;  hyperthyroidism;  hypothyroidism;  incidence;  infusion related reaction;  iritis;  Letter;  leukemia relapse;  major clinical study;  male;  monotherapy;  myocarditis;  myositis;  overall survival;  pneumonia;  priority journal;  progression free survival;  salvage therapy;  sarcoidosis;  treatment duration;  treatment response;  treatment response time;  treatment withdrawal;  autotransplantation;  hematopoietic stem cell transplantation;  Hodgkin disease;  stem cell transplantation;  tumor recurrence, Antibodies, Monoclonal, Humanized;  Brentuximab Vedotin;  Hematopoietic Stem Cell Transplantation;  Hodgkin Disease;  Humans;  Immunoconjugates;  Neoplasm Recurrence, Local;  Salvage Therapy;  Stem Cell Transplantation;  Transplantation, Autologous
TODO - null
ER -